Newton Biocapital’s ESG Compliance
Entity Level Disclosure
Newton Biocaptial’s mission is to leverage innovation and support the growth of our portfolio companies to create value for patients by providing affordable healthcare solutions to their unmet medical needs, for society by alleviating pressure on reimbursement systems burdened by chronic health conditions, for local ecosystems by supporting company growth which leads to greater sector employment, and for investors by setting the scene for good financial returns.
Since we started in 2017, we have been committed to sustainable development and responsible investment. While Environmental, Social and Corporate Governance issues have received a lot more attention in recent years, integrating material, non-financial issues have always been essential to our investment risk-analysis and decision-making.
Newton Biocapital Partners SRL, the Fund Manager of Newton’s first Fund Newton Biocapital I, pricaf privée de droit belge, S.A. (“NBC I”) inherently addressed sustainability factors into its decision-making process as part of its investment strategy. It did not formally adopt a Sustainability Risk Policy prior to making the investments, and therefore, to comply with SFDR disclosure requirements (Regulation (EU) 2019/2088 of the European Parliament and of the Council of 27 November 2019 on sustainability-related disclosures in the financial services sector), it chose to declare not to have integrated sustainability risks and Principle Adverse Impacts on Sustainability (“PAIS”) in its investment decisions. Reason is that it was no longer soliciting for new investors in NBC I and it was no longer looking to add new companies to NBC I’s portfolio when the regulation came into force.
We are convinced that mitigating sustainability risks by taking material ESG factors into account improves our investment decisions and lowers the financial risks for our investors. Newton Biocapital II SRL, fund manager of Newton Biocapital II, pricaf privée de droit belge, S.A. (“NBC II”) therefore sees the integration of a sustainability risk policy as a natural step in its investment process (disclosure as required under Article 3 of the SFDR - Regulation (EU) 2019/2088 of the European Parliament and of the Council of 27 November 2019 on sustainability-related disclosures in the financial services sector). Download Newton Biocapital II Partners’ Policy on the integration of Sustainability Risks via the 'ESG Policy' button below.